Mainstream

Adaptive Biotechnologies targets $1,300 ASP for MRD tests in 2025 driven by pricing improvements

Adaptive Biotechnologies targets $1,300 ASP for MRD tests in 2025 driven by pricing improvements

Post ContentadptRead More

You might also be interested in reading New bill aims to ‘mitigate risks’ to US from El Salvador’s Bitcoin Law.

February 12, 2025
In Mainstream